Literature DB >> 22778229

Prenatal exposure to low levels of androgen accelerates female puberty onset and reproductive senescence in mice.

Emily A Witham1, Jason D Meadows, Shadi Shojaei, Alexander S Kauffman, Pamela L Mellon.   

Abstract

Sex steroid hormone production and feedback mechanisms are critical components of the hypothalamic-pituitary-gonadal (HPG) axis and regulate fetal development, puberty, fertility, and menopause. In female mammals, developmental exposure to excess androgens alters the development of the HPG axis and has pathophysiological effects on adult reproductive function. This study presents an in-depth reproductive analysis of a murine model of prenatal androgenization (PNA) in which females are exposed to a low dose of dihydrotestosterone during late prenatal development on embryonic d 16.5-18.5. We determined that PNA females had advanced pubertal onset and a delay in the time to first litter, compared with vehicle-treated controls. The PNA mice also had elevated testosterone, irregular estrous cyclicity, and advanced reproductive senescence. To assess the importance of the window of androgen exposure, dihydrotestosterone was administered to a separate cohort of female mice on postnatal d 21-23 [prepubertal androgenization (PPA)]. PPA significantly advanced the timing of pubertal onset, as observed by age of the vaginal opening, yet had no effects on testosterone or estrous cycling in adulthood. The absence of kisspeptin receptor in Kiss1r-null mice did not change the acceleration of puberty by the PNA and PPA paradigms, indicating that kisspeptin signaling is not required for androgens to advance puberty. Thus, prenatal, but not prepubertal, exposure to low levels of androgens disrupts normal reproductive function throughout life from puberty to reproductive senescence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22778229      PMCID: PMC3423623          DOI: 10.1210/en.2012-1283

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  36 in total

1.  Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and beta in vitro.

Authors:  M Casanova; L You; K W Gaido; S Archibeque-Engle; D B Janszen; H A Heck
Journal:  Toxicol Sci       Date:  1999-10       Impact factor: 4.849

2.  Nature of induced persistent vaginal cornification in mice. 3. Effects of estradiol and testosterone on vaginal epithelium in vitro.

Authors:  T Kimura; S L Basu; S Nandi
Journal:  J Exp Zool       Date:  1967-08

3.  Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues.

Authors:  Shuyuan Yeh; Meng-Yin Tsai; Qingquan Xu; Xiao-Min Mu; Henry Lardy; Ko-En Huang; Hank Lin; Shauh-Der Yeh; Saleh Altuwaijri; Xinchang Zhou; Lianping Xing; Brendan F Boyce; Mien-Chie Hung; Su Zhang; Lin Gan; Chawnshang Chang; Min-Chi Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

Review 4.  Neuroendocrine control of the transition to reproductive senescence: lessons learned from the female rodent model.

Authors:  Bailey A Kermath; Andrea C Gore
Journal:  Neuroendocrinology       Date:  2012-02-17       Impact factor: 4.914

5.  Subfertility and defective folliculogenesis in female mice lacking androgen receptor.

Authors:  Yueh-Chiang Hu; Peng-Hui Wang; Shuyuan Yeh; Ruey-Sheng Wang; Chao Xie; Qingquan Xu; Xinchang Zhou; Hsiang-Tai Chao; Meng-Yin Tsai; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

6.  Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.

Authors:  Lourdes Ibáñez; Angela Ferrer; Ken Ong; Rakesh Amin; David Dunger; Francis de Zegher
Journal:  J Pediatr       Date:  2004-01       Impact factor: 4.406

7.  The GPR54 gene as a regulator of puberty.

Authors:  Stephanie B Seminara; Sophie Messager; Emmanouella E Chatzidaki; Rosemary R Thresher; James S Acierno; Jenna K Shagoury; Yousef Bo-Abbas; Wendy Kuohung; Kristine M Schwinof; Alan G Hendrick; Dirk Zahn; John Dixon; Ursula B Kaiser; Susan A Slaugenhaupt; James F Gusella; Stephen O'Rahilly; Mark B L Carlton; William F Crowley; Samuel A J R Aparicio; William H Colledge
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

8.  Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54.

Authors:  Nicolas de Roux; Emmanuelle Genin; Jean-Claude Carel; Fumihiko Matsuda; Jean-Louis Chaussain; Edwin Milgrom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-27       Impact factor: 11.205

9.  Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder.

Authors:  Shannon D Sullivan; Suzanne M Moenter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

Review 10.  Wired for reproduction: organization and development of sexually dimorphic circuits in the mammalian forebrain.

Authors:  Richard B Simerly
Journal:  Annu Rev Neurosci       Date:  2002-03-27       Impact factor: 12.449

View more
  25 in total

1.  Female Offspring From Chronic Hyperandrogenemic Dams Exhibit Delayed Puberty and Impaired Ovarian Reserve.

Authors:  Zhiqiang Wang; Mingjie Shen; Ping Xue; Sara A DiVall; James Segars; Sheng Wu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

2.  Stability of proposed biomarkers of prenatal androgen exposure over the menstrual cycle.

Authors:  E S Barrett; L E Parlett; S H Swan
Journal:  J Dev Orig Health Dis       Date:  2015-01-13       Impact factor: 2.401

3.  Androgens Mediate Sex-Dependent Gonadotropin Expression During Late Prenatal Development in the Mouse.

Authors:  Michael J Kreisman; Christopher I Song; Kathleen Yip; Bryony V Natale; David R Natale; Kellie M Breen
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

4.  Hyperandrogenemia Induced by Letrozole Treatment of Pubertal Female Mice Results in Hyperinsulinemia Prior to Weight Gain and Insulin Resistance.

Authors:  Danalea V Skarra; Angelina Hernández-Carretero; Alissa J Rivera; Arya R Anvar; Varykina G Thackray
Journal:  Endocrinology       Date:  2017-09-01       Impact factor: 4.736

Review 5.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

6.  Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.

Authors:  Aleisha M Moore; Mel Prescott; Christopher J Marshall; Siew Hoong Yip; Rebecca E Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-30       Impact factor: 11.205

7.  Prepubertal Development of GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons and Postsynaptic Response Are Altered by Prenatal Androgenization.

Authors:  Tova Berg; Marina A Silveira; Suzanne M Moenter
Journal:  J Neurosci       Date:  2018-01-26       Impact factor: 6.167

8.  Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice.

Authors:  Jessica M Crain; Maria Nikodemova; Jyoti J Watters
Journal:  J Neurosci Res       Date:  2013-05-17       Impact factor: 4.164

Review 9.  Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models.

Authors:  Alison V Roland; Suzanne M Moenter
Journal:  Front Neuroendocrinol       Date:  2014-04-18       Impact factor: 8.606

10.  Voluntary Exercise Improves Estrous Cyclicity in Prenatally Androgenized Female Mice Despite Programming Decreased Voluntary Exercise: Implications for Polycystic Ovary Syndrome (PCOS).

Authors:  Lori D Homa; Laura L Burger; Ashley J Cuttitta; Daniel E Michele; Suzanne M Moenter
Journal:  Endocrinology       Date:  2015-09-10       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.